Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2238394
Max Phase: Preclinical
Molecular Formula: C20H18BrNO3S
Molecular Weight: 432.34
Molecule Type: Small molecule
Associated Items:
ID: ALA2238394
Max Phase: Preclinical
Molecular Formula: C20H18BrNO3S
Molecular Weight: 432.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(OCc3ccc(Br)cc3)cc2)cc1
Standard InChI: InChI=1S/C20H18BrNO3S/c1-15-2-12-20(13-3-15)26(23,24)22-18-8-10-19(11-9-18)25-14-16-4-6-17(21)7-5-16/h2-13,22H,14H2,1H3
Standard InChI Key: PIGXWLPTUPTMDO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 432.34 | Molecular Weight (Monoisotopic): 431.0191 | AlogP: 5.14 | #Rotatable Bonds: 6 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.24 | CX Basic pKa: | CX LogP: 5.31 | CX LogD: 5.26 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.59 | Np Likeness Score: -1.43 |
1. Abu Khalaf R, Abu Sheikha G, Al-Shaer M, Albadawi G, Taha M. (2012) Design, synthesis, and biological evaluation of sulfonic acid ester and benzenesulfonamide derivatives as potential CETP inhibitors, 21 (11): [10.1007/s00044-011-9917-5] |
Source(1):